• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    Ruthigen, Inc. (RTGN)

    -NasdaqCM
    3.79 Down 0.08(2.07%) 3:57PM EST
    Add to Portfolio
    Prev Close:3.87
    Open:3.89
    Bid:N/A
    Ask:4.43 x 1600
    1y Target Est:12.00
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:3.76 - 3.90
    52wk Range:3.31 - 8.47
    Volume:1,877
    Avg Vol (3m):12,160
    Market Cap:18.21M
    P/E (ttm):N/A
    EPS (ttm):-1.48
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RTGN

    Comparison

    Symbol% ChgMkt Cap
    RTGNDown 2.07%18.21M
    NBYDown 15.25%25.81M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Mar-15) :-1.40
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ruthigen, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid based therapeutics to prevent and treat infection in invasive applications. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback